MENU

NTLA Intellia Therapeutics Forecast, Technical & Fundamental Analysis

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more

Industry: #Biotechnology
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
NTLA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

NTLA is expected to report earnings to -79 cents per share on November 05

Intellia Therapeutics NTLA Stock Earnings Reports
Q3'26
Est.
$-0.80
Q2'26
Est.
$-0.80
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.09
The last earnings report on August 06 showed earnings per share of -80 cents, meeting the estimate of -80 cents. With 1.76M shares outstanding, the current market capitalization sits at 1.66B.
A.I. Advisor
published General Information

General Information

a developer of proprietary, potentially curative therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ITDJ33.900.19
+0.57%
iShares LifePath Target Date 2070 ETF
NPCT9.870.04
+0.41%
Nuveen Core Plus Impact Fund
IBTJ21.580.03
+0.14%
iShares iBonds Dec 2029 Term Tr ETF
SAEF24.27N/A
N/A
Schwab Ariel ESG ETF
IONL17.22-0.25
-1.43%
GraniteShares 2x Long IONQ Daily ETF

NTLA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-2.15%
VCYT - NTLA
69%
Closely correlated
-4.66%
CRSP - NTLA
61%
Loosely correlated
N/A
BEAM - NTLA
59%
Loosely correlated
-0.75%
EDIT - NTLA
56%
Loosely correlated
-1.06%
PRME - NTLA
56%
Loosely correlated
-0.94%
More
Intellia Therapeutics (NTLA) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com